EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 3rd, 2012 • RedHill Biopharma Ltd. • Pharmaceutical preparations • England
Contract Type FiledDecember 3rd, 2012 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made and entered into effective as of November 18, 2009 (the “Effective Date”), by and between Egalet a/s, a Danish corporation also registered under the name BM Research a/s (“Egalet”), and RedHill Biopharma Ltd., an Israeli company (“RedHill”). Egalet and RedHill each may be referred to herein individually as a “Party,” or collectively as the “Parties”.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 26th, 2012 • RedHill Biopharma Ltd. • Pharmaceutical preparations • England
Contract Type FiledOctober 26th, 2012 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made and entered into effective as of November 18, 2009 (the “Effective Date”), by and between Egalet a/s, a Danish corporation also registered under the name BM Research a/s (“Egalet”), and RedHill Biopharma Ltd., an Israeli company (“RedHill”). Egalet and RedHill each may be referred to herein individually as a “Party,” or collectively as the “Parties”.